Edition:
India

Zosano Pharma Corp (ZSAN.OQ)

ZSAN.OQ on NASDAQ Stock Exchange Capital Market

0.45USD
19 Jan 2018
Change (% chg)

$-0.04 (-7.22%)
Prev Close
$0.49
Open
$0.49
Day's High
$0.49
Day's Low
$0.40
Volume
229,804
Avg. Vol
139,079
52-wk High
$3.53
52-wk Low
$0.40

Chart for

About

Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company. The Company has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Its microneedle patch system offers consistent drug delivery and improved... (more)

Overall

Beta: --
Market Cap(Mil.): $33.27
Shares Outstanding(Mil.): 39.23
Dividend: --
Yield (%): --

Financials

BRIEF-Zosano Pharma Files For Offering Of Up To $57.5 Million Shares

* ZOSANO PHARMA FILES FOR OFFERING OF UP TO $57.5 MILLION SHARES - SEC FILING Source text :[http://bit.ly/2BPJFqj] Further company coverage:

23 Dec 2017

BRIEF-Zosano Pharma Says Board To Reduce Size To Five

* ZOSANO PHARMA SAYS BOARD OF DIRECTORS ADOPTED A RESOLUTION TO REDUCE SIZE OF BOARD TO FIVE DIRECTORS - SEC FILING Source: (http://bit.ly/2j7YwDM) Further company coverage:

16 Dec 2017

BRIEF-Zosano pharma Q3 loss per share $0.20

* Zosano pharma reports third quarter 2017 financial results and operational update

10 Nov 2017

BRIEF-Zosano Pharma announces initiation of long-term safety study for M207

* Zosano Pharma announces initiation of long-term safety study for M207 as an acute treatment of migraine Source text for Eikon: Further company coverage:

08 Nov 2017

BRIEF-Zosano enters into common stock purchase agreement with Lincoln Park Capital

* Zosano enters into common stock purchase agreement with Lincoln Park Capital Source text for Eikon: Further company coverage:

21 Oct 2017

BRIEF-Zosano appoints Kenneth Greathouse to board of directors

* Zosano appoints Kenneth Greathouse to board of directors Source text for Eikon: Further company coverage:

04 Oct 2017

BRIEF-Zosano provides patent application update

* Zosano Pharma Corp - Received official written notification of an office action from U.S. patent and trademark office

27 Sep 2017

BRIEF-Zosano Pharma Q2 loss per share $0.17

* Zosano Pharma reports second quarter 2017 financial results and operational update

11 Aug 2017

Earnings vs. Estimates